narlaprevir,
SCH 900518,
SCH-900518,
SCH900518,
Narlaprevir,
865466-24-6,
SCH900518,
UNII-2857LA2O07,
SCH 900518,
SCH-900518,
2857LA2O07,
Narlaprevir (USAN/INN),
SCHEMBL583183,
CHEMBL1255891,
C36H61N5O7S,
3912AH,
ZINC68151111,
CS-0445,
SB16894,
HY-10300,
D09644,
W-5628,
(1R,2S,5S)-3-[N-({1-[(tert-Butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxoheptan-3-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide,
(1S,4S,5R)-3-[(2S)-2-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-3,3-dimethyl-butanoyl]-N-[(1S)-1-[2-(cyclopropylamino)-2-oxo-acetyl]pentyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-4-carboxamide,
(3S)-N-CYCLOPROPYL-3-{[(1R,2S,5S)-3-[(2S)-3,3-DIMETHYL-2-[({1-[(2-METHYLPROPANE-2-SULFONYL)METHYL]CYCLOHEXYL}CARBAMOYL)AMINO]BUTANOYL]-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXAN-2-YL]FORMAMIDO}-2-OXOHEPTANAMIDE,
Narlaprevir [USAN],
Narlaprevir [USAN:INN],
Narlaprevir; SCH 900518,
CID11857239,
CID 11857239,
A3643,
(1R,2S,5S)-3-(N-(((1-((tert-butylsulfonyl)methyl)cyclohexyl)amino)carbonyl)-3-methyl-l- valyl)-N-((1s)-1-((cyclopropylamino)(oxo)acetyl)pentyl)-6,6-dimethyl-3- azabicyclo(3.1.0)hexane-2-carboxamide,
(1R,2S,5S)-N-((1S)-1-(2-(cyclopropylamino)-2-oxoacetyl)pentyl)-3-((2S)-2-(((1-(((1,1- dimethylethyl)sulfonyl)methyl)cyclohexyl)carbamoyl)amino)-3,3-dimethylbutanoyl)-6,6- dimethyl-3-azabicyclo(3.1.0)hexane-2-carboxamide,
3-Azabicyclo(3.1.0)hexane-2-carboxamide, N-((1S)-1-(2-(cyclopropylamino)-2- oxoacetyl)pentyl)-3-((2s)-2-((((1-(((1,1-dimethylethyl)sulfonyl)methyl)cyclohexyl) amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-, (1R,2S,5S)-,